Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung

7680626260014 CH-62626 Infusionslösung
Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung
Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung
Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/09/2024
Summary of Product Characteristics
Français
17/09/2024
Summary of Product Characteristics
Italien
17/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
7.0 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 220.65
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2012

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
62626
Drug name
Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung
Galenic form
LSINF
ATC Code
M05BA08
Authorization status
Z
Authorization category
Category C
Dispensing category
B
First authorization
29/03/2012
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Morbus Paget, postmenopausale Osteoporose

Package details

Description (FR)
ZOLEDRONATE OSTEO Sandoz 5 mg/100ml amp 100 ml
Description (DE)
ZOLEDRONAT OSTEO Sandoz 5 mg/100ml Amp 100 ml
Market launch
29/03/2012
Narcotic (BTM)
No

Original drug

Aclasta, Infusionslösung
GTIN: 7680573630014
CHF 254.45
View original